Trials / Conditions / HR Positive/HER2 Low Breast Cancer
HR Positive/HER2 Low Breast Cancer
3 registered clinical trials studyying HR Positive/HER2 Low Breast Cancer — 3 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Not Yet Recruiting | Chemotherapy With or Without Adebrelimab and T-DXh as Neoadjuvant Therapy for HR+/HER2 Low Early Stage Breast NCT07317778 | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | Phase 2 |
| Recruiting | Neoadjuvant Therapy Combined With Trastuzumab Rezetecan and Toripalimab for HR+/HER2-low Breast Cancer (NEOTOR NCT07383818 | First Affiliated Hospital of Zhejiang University | Phase 2 |
| Recruiting | SHR-A1811 Alone or in Combination With Adebrelimab as Neoadjuvant Treatment in HR Positive/HER2 Low Breast Can NCT06340230 | Shengjing Hospital | Phase 2 |